SCHEMBL15544206

SCHEMBL15544206

CCCN(c1ccc(F)c(C(=O)O)c1F)[SH](=O)=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 3/20 0.34
HCAR3 P49019 4/20 0.33
PLK3 Q9H4B4 2/20 0.33
POLB P06746 1/20 0.33
APEX1 P27695 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LPAR1 Q92633 1/20 0.32
LPAR5 Q9H1C0 1/20 0.32
CA12 O43570 1/20 0.32
CA2 P00918 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CA9 Q16790 1/20 0.32
SLC22A6 Q4U2R8 1/20 0.32
SLC22A8 Q8TCC7 1/20 0.32
ABCC2 Q92887 1/20 0.32
SLC22A12 Q96S37 1/20 0.32
UGT1A7 Q9HAW7 1/20 0.32
SLC22A11 Q9NSA0 1/20 0.32
MLYCD O95822 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28740457 0.84 LPAR1 (0.35) POLBLPAR1LPAR5
SCHEMBL1592968 0.77 ESR1 (0.38) HCAR3CA12CA2RAB9ASMN1; SMN2
SCHEMBL8001344 0.74 BRAF (0.34) PLK1LMNA
SCHEMBL28691752 0.73
SCHEMBL1437491 0.72 AKR1B1 (0.34) PLK1TDP1LMNA
SCHEMBL17202417 0.70 CES2 (0.35) CA12CA2SMN1; SMN2CA9
SCHEMBL7799718 0.70 METAP2 (0.39) PLK1SMN1; SMN2ALDH1A1
SCHEMBL1490950 0.69 LMNA (0.39) POLBSMN1; SMN2ALDH1A1LMNANPSR1
SCHEMBL31258574 0.68 CES2 (0.47) CA12CA2SMN1; SMN2CA9ALDH1A1
SCHEMBL365563 0.68 CES2 (0.47) CA12CA2SMN1; SMN2CA9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2870154-A1 SOLID STATE FORM OF VEMURAFENIB CHOLINE SALT Ratiopharm GmbH (DE) 2015-05-13 EP disclosed
WO-2014008270-A1 SOLID STATE FORM OF VEMURAFENIB CHOLINE SALT RATIOPHARM GMBH (DE) 2014-01-09 WO disclosed